Preliminary Experience of Cetuximab in the Treatment of Advanced-Stage Biliary Tract Cancer

Publisher： Karger

E-ISSN： 2296-5262|33|1-2|45-47

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.1-2, 2010-01, pp. : 45-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy with Gemcitabine and Oxaliplatin in Patients with Advanced Biliary Tract Cancer: A Single-Institution Experience

By  

Oncology, Vol. 73, Iss. 5-6, 2008-05 ,pp. : 311-315

Karger

Access to resources Recommend Favorite

Renal Toxicity Associated with Weekly Cisplatin and Gemcitabine Combination Therapy for Treatment of Advanced Biliary Tract Cancer

By  

Oncology, Vol. 87, Iss. 1, 2014-06 ,pp. : 30-39

Karger

Access to resources Recommend Favorite

Imatinib Mesylate for Palliative Second-Line Treatment of Advanced Biliary Tract Cancer: A Bicentric Phase II Study

By  

Oncology Research and Treatment, Vol. 34, Iss. 8-9, 2011-08 ,pp. : 469-470

Karger

Access to resources Recommend Favorite

Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 39-45

Karger

Access to resources Recommend Favorite

S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer

By  

Oncology, Vol. 77, Iss. 1, 2009-06 ,pp. : 71-74

Karger

Access to resources Recommend Favorite